In patients with cardiovascular disease, oral doses of L-carnitine more than 3 g/day have resulted in a higher risk of atherogenesis and CVD
A protocol that includes both a central-acting peptide like Selank or Semax and a gut-healing peptide like BPC-157 or KPV targets the mood disorder from both directions simultaneously
VDR functions as a tumor suppressor by antagonizing the Wnt/-catenin pathway, thereby inhibiting cancer cell proliferation and invasiveness and promoting apoptosis in several tumor types [i.e., colorectal (48, 49), breast (50), gastric cancer (51), melanoma (52)]
Novo argues this brings Wegovy's efficacy in line with Zepbound, undercutting Lilly's comparative claims
The MB System launched on March 15, 2025, for LifeVantage Consultants in multiple countries, with broader customer access starting April 25